FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/ABBV
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

AbbVie Inc (ABBV) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

AbbVie (ABBV) trades at $284.72, down 1.48% on the day, with strong technical momentum showing bullish moving averages and key support at $282. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $3.65 versus $3.61, while revenue growth accelerated to $61.16B in 2025. Recent positive Phase 2 data for ELAHERE in ovarian cancer highlights pipeline strength.
With 73% analyst buy ratings and a $294 consensus price target offering 3.3% upside, ABBV presents a compelling growth story despite high valuation multiples. Key risks include patent cliffs in the 2030s and elevated debt levels at 50.4% debt-to-asset ratio, but strong immunology portfolio and dividend growth support long-term value.
Read full analysis

Key Stats

  • Market Cap
    $503.96B
  • Volume
    5,849,111
  • Sector
    Health
  • 52W High
    $289.00
  • 52W Low
    $197.38
  • Typical Hold Time
    93 Days
  • Enterprise Value
    $568.22B
  • Div Yield
    2.43%
  • Trading Activity
    42% Sell | 58% Buy
$284.76
52W Low: $197.38
27 Apr 2026
52W High: $289
20 Oct 2026

Track AbbVie Inc (ABBV) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbbVie Inc has traded between a low of $197.38 and a high of $289, highlighting its annual price range. Buy and sell AbbVie Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Most Recent News

Content is generated by Aura AI

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
44 minutes ago
Avacta Therapeutics
Bullish
news icon
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

EssilorLuxottica's credit rating raised to A+ by S&P, reflecting strong growth and financial health.

EssilorLuxottica announced that S&P Global Ratings has upgraded its long-term credit rating to A+ with a stable outlook. This upgrade recognizes the company's strong organic growth, robust cash flow, and solid balance sheet. S&P also highlighted the ...

Market News
2 hours ago
Na
Bullish
news icon
EssilorLuxottica's credit rating raised to A+ by S&P, reflecting strong growth and financial health.

Questrade launches pre- and post-market equity options trading for faster reaction to news.

Questrade now offers pre-market (7:30 am to 9:25 am ET) and post-market (4:00 pm to 4:15 pm ET) trading for equity options on 29 selected stocks and ETFs, including major names like AAPL and TSLA. This allows investors to respond to earnings reports ...

Market News
2 hours ago
Na
Bullish
news icon
Questrade launches pre- and post-market equity options trading for faster reaction to news.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $503.96B
  • Volume
    5,849,111
  • Sector
    Health
  • 52W High
    $289.00
  • 52W Low
    $197.38
  • Typical Hold Time
    93 Days
  • Enterprise Value
    $568.22B
  • Div Yield
    2.43%
  • Trading Activity
    42% Sell | 58% Buy
$284.76
52W Low: $197.38
27 Apr 2026
52W High: $289
20 Oct 2026

Track AbbVie Inc (ABBV) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbbVie Inc has traded between a low of $197.38 and a high of $289, highlighting its annual price range. Buy and sell AbbVie Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!